EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Therapeutic Controlled Release Strategies for Human Osteoarthritis

Dan Wang, Wei Liu, Jagadeesh K Venkatesan, Henning Madry, Magali Cucchiarini iD

Advanced Healthcare Materials · 2025-01 · 14 (2)

DOI: 10.1002/adhm.202402737 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, online erschienen am 06.11.2024. Verfasst von Dan Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center of Experimental Orthopaedics, Saarland University and Saarland University Medical Center, Kirrbergerstr. Bldg 37, D-66421, Homburg/Saar, Germa…. Hauptthemen laut MEDLINE: Osteoarthritis, Delayed-Action Preparations, Drug Delivery Systems. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 631 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: China Scholarship Council, Deutsche Arthrose-Hilfe e.V.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoarthritis is a progressive, irreversible debilitating whole joint disease that affects millions of people worldwide. Despite the availability of various options (non‐pharmacological and pharmacological treatments and therapy, orthobiologics, and surgical interventions), none of them can definitively cure osteoarthritis in patients. Strategies based on the controlled release of therapeutic compounds via biocompatible materials may provide powerful tools to enhance the spatiotemporal delivery, expression, and activities of the candidate agents as a means to durably manage the pathological progression of osteoarthritis in the affected joints upon convenient intra‐articular (injectable) delivery while reducing their clearance, dissemination, or side effects. The goal of this review is to describe the current knowledge and advancements of controlled release to treat osteoarthritis, from basic principles to applications in vivo using therapeutic recombinant molecules and drugs and more innovatively gene sequences, providing a degree of confidence to manage the disease in patients in a close future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoarthritisDelayed-Action PreparationsDrug Delivery SystemsHumansAnimalsBiocompatible Materials

Stichwörter der Autor:innen

biomaterialscontrolled releasedrugsgene sequencesin vivoosteoarthritisrecombinant molecules

Substanzen

Delayed-Action PreparationsBiocompatible Materials

Autor:innen und Institutionen

  • Center of Experimental Orthopaedics, Saarland University and Saarland University Medical Center, Kirrbergerstr. Bldg 37, D-66421, Homburg/Saar, Germany.

ORCID-Profile: Magali Cucchiarini

Förderung

  • China Scholarship Council
  • Deutsche Arthrose-Hilfe e.V

Zitieren

APA

Wang, D., Liu, W., Venkatesan, J. K., Madry, H., & Cucchiarini, M. (2025). Therapeutic Controlled Release Strategies for Human Osteoarthritis. Advanced Healthcare Materials, 14(2). https://doi.org/10.1002/adhm.202402737

Vancouver

Wang D, Liu W, Venkatesan JK, Madry H, Cucchiarini M. Therapeutic Controlled Release Strategies for Human Osteoarthritis. Advanced Healthcare Materials. 2025;14(2). doi:10.1002/adhm.202402737

BibTeX
@article{Wang2025,
  author = {Wang, Dan and Liu, Wei and Venkatesan, Jagadeesh K and Madry, Henning and Cucchiarini, Magali},
  title = {Therapeutic Controlled Release Strategies for Human Osteoarthritis},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  volume = {14},
  number = {2},
  doi = {10.1002/adhm.202402737}
}
Kostenlos starten →